http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1336441-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0cb7734bc2e5840db630f0ae7c29684
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-213
filingDate 1970-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1973-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1336441-A
titleOfInvention Derivatives of cyclo adenosine-3,5-phosphoric acid and their preparation
abstract 1336441 Cycloadenosine - 3<SP>1</SP>,5<SP>1</SP> - phosphoric acid derivatives AGENCE NATIONALE DE VALORISATION DE LA RECHERCHE 7 Oct 1970 [10 Oct 1969 2 Oct 1970] 47731/70 Heading C2P The invention comprises (A) an N<SP>6</SP>-, 2<SP>1</SP>-O-, N<SP>8</SP>- and/or N<SP>2</SP>-butyrylated derivative of a compound of Formula I where (a) R 1 and R 2 are hydrogen, one of X and Y is hydrogen or C 1-4 alkyl and the other is C 1-4 alkyl, or (b) X and Y are hydrogen, R 1 is hydrogen, bromine, sulphhydryl, hydroxy, methylthio or amino and R 2 is hydrogen or amino, with the proviso that X, Y, R 1 and R 2 are not all hydrogen; (B) 2<SP>1</SP>-O-butyryl-cycloiso-adenosine-3<SP>1</SP>,5<SP>1</SP>-monophosphoric acid and (C) a salt of (A) or (B) wherein the OH linked to phosphorus is salified. The compounds of the invention may be prepared by reacting a compound of Formula I, or iso-adenosine-3<SP>1</SP>,5<SP>1</SP>- monophosphoric acid or a salt thereof with a butyrylating agent such as butyric anhydride, and optionally forming a salt. The compounds of the invention have a biological activity similar to that of cyclo-AMP.
priorityDate 1969-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 27.